Literature DB >> 6477956

Purification and characterization of human plasma proteins that inhibit lipid transfer activities.

Y S Son, D B Zilversmit.   

Abstract

A protein which inhibits cholesteryl ester and triacylglycerol transfer activities was purified from human lipoprotein-deficient plasma by chromatography on phenyl-Sepharose CL-4B, chromatofocusing, Bio-Gel A-0.5m and hydroxylapatite. The inhibitor is a sialoglycoprotein with molecular weight 32 000 and a relatively broad isoelectric region of 3.9-4.3. The inhibitor suppressed triacylglycerol and cholesteryl ester transfer activities to a similar extent. Apolipoprotein A-I, which was separated from the inhibitor by chromatofocusing chromatography, suppressed triacyglycerol transfer more than cholesteryl ester transfer. The percentage reduction of lipid transfer between lipoproteins by the inhibitor was independent of the concentration of transfer protein but was decreased at higher lipoprotein concentrations. The inhibition was not observed during lipid transfer between liposomes. These results indicate that the inhibitor interacts with substrates rather than with the transfer protein.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477956     DOI: 10.1016/0005-2760(84)90175-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.

Authors:  Yan Liu; Richard E Morton
Journal:  Curr Opin Lipidol       Date:  2020-08       Impact factor: 4.776

Review 2.  Interaction of lipid transfer protein with plasma lipoproteins and cell membranes.

Authors:  R E Morton
Journal:  Experientia       Date:  1990-06-15

3.  Conformational studies of the N-terminal lipid-associating domain of human apolipoprotein C-I by CD and 1H NMR spectroscopy.

Authors:  A Rozek; G W Buchko; P Kanda; R J Cushley
Journal:  Protein Sci       Date:  1997-09       Impact factor: 6.725

Review 4.  Apolipoproteins in lipid transport, an impressionist view.

Authors:  D W Erkelens
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

5.  Structural studies of a baboon (Papio sp.) plasma protein inhibitor of cholesteryl ester transferase.

Authors:  G W Buchko; A Rozek; P Kanda; M A Kennedy; R J Cushley
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

6.  ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.

Authors:  Richard E Morton; Yan Liu; Lahoucine Izem
Journal:  J Lipid Res       Date:  2019-09-11       Impact factor: 5.922

7.  Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids.

Authors:  R P Dullaart; J E Groener; L D Dikkeschei; D W Erkelens; H Doorenbos
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

8.  Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein.

Authors:  A Tall; E Granot; R Brocia; I Tabas; C Hesler; K Williams; M Denke
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

9.  A hyperalphalipoproteinaemic family with normal cholesteryl ester transfer/exchange activity.

Authors:  J E Groener; P G da Col; G M Kostner
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

10.  Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency.

Authors:  H Akita; H Chiba; M Tsuji; S P Hui; Y Takahashi; K Matsuno; K Kobayashi
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.